相关实验视频
Updated: Jun 11, 2025

07:48
Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
Published on: June 8, 2019
8.7K
慢性肢体威胁性缺血症患者的治疗性血管生成:有希望的还是骗局?
Judith A H M Peeters1,2, Abbey Schepers1, Jaap F Hamming1
1Department of Vascular Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Vascular biology (Bristol, England)
|October 7, 2024
概括
慢性四肢威胁性缺血症 (CLTI) 的治疗性血管新生有希望,但面临挑战. 糟糕的试验设计和选择性出版掩盖了真正的治疗疗效,阻碍了减少截肢的进展.
科学领域:
- 血管医学 血管医学
- 再生医学是一种再生医学.
- 临床试验设计 临床试验设计
背景情况:
- 慢性肢体威胁性缺血 (CLTI) 是一种严重的疾病,截肢率很高.
- 治疗性血管生成,包括基因和细胞疗法,旨在恢复血液流动并防止截肢.
- 对于CLTI的早期试验经常报告有希望但不确定的结果.
研究的目的:
- 审查设计和进行CLTI临床试验的挑战.
- 倡导严格的试验方法和所有结果的透明报告.
- 解决治疗新血管化的持续"有希望但尚未被证明"的状况.
主要方法:
- 在CLTI中对治疗性血管生成试验的文献综述.
- 分析导致试验失败和出版偏见的因素.
- 讨论未来CLTI临床试验设计的最佳实践.
主要成果:
- 许多早期CLTI试验未能证明有显著的临床益处.
- 随后基于不确定的早期数据的III期试验始终失败.
- 严格的纳入标准往往限制了患者参加CLTI试验的资格.
结论:
- 设计有效的CLTI试验是复杂的,因为患者的资格和方法问题.
- 具有完全结果发表的低风险偏差试验对于验证疗法至关重要.
- 赞成低质量研究的积极结果的出版偏见使未经验证的说法延续.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
3
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
3
Peripheral Artery Disease V: Postoperative Nursing Management
4
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
4
Mechanism of Angiogenesis
5.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.3K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Venous Thrombosis III: Interprofessional Care
3
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
3

